TurboCBD: Achieve 10x Absorption with Focus, Memory & Stress Relief
June 8th, 2017
News, Top News
The popularity of cannabidiol (CBD) has been soaring as researchers continue to uncover the potential therapeutic benefits of the cannabinoid. Hemp-based CBDs are non-psychoactive and legal to buy throughout the United States, but these products aren’t regulated by the Food & Drug Administration (FDA) and finding high quality products can be difficult. In fact, a recent FDA investigation found that many CBD products contained no CBD at all!
Lexaria Bioscience Corp.’s TurboCBD™ capsules contain high-absorption, full-spectrum hemp oil with CBDs along with the finest American Ginseng and Ginkgo Biloba for enhanced focus and memory as well as the reduction of stress and fatigue.
In-vitro and human studies have shown that TurboCBD™ provides five to ten times more CBD absorption than conventional preparations while taking effect in as little as 15 minutes.
And while many companies purchase bulk hemp oil from China, the company’s vegan, gluten-free, sugar-free, and nut-free capsules are made in the United States from European Union-certified organic hemp and triple-tested for purity and potency.
- FASTEST ACTING
- UP TO 1,000% HIGHER ABSORPTION THAN OTHER BRANDS
- GUARANTEED POTENCY
TurboCBD™ leverages a patented absorption technology that’s designed to work with the physiology of the human gastrointestinal system. Minute quantities of long chain fatty acids – such as sunflower oil – are molecularly combined with CBD to be thoroughly and quickly absorbed into the circulatory system for maximum effects. The delivery technology also helps enhance flavor and avoid the bad aftertaste that’s often associated with hemp oil.
TurboCBD™ is backed by a publicly-traded food biosciences company that’s partly funded by the Canadian government to develop cannabinoid therapeutics. Consumers can be confident that they’re buying only the highest quality CBD products on the market.
Absorb more CBD than with any competitor’s product. Consumers can receive an instant 15% discount using the code CFN015 by calling toll free at 1-888-976-8482. This is a limited time introductory offer and will expire soon. More information at www.turbo-cbd.com.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.